What absolute eosinophil count (AEC) thresholds define eosinophilia and its severity (mild, moderate, severe), as well as the criteria for hypereosinophilic syndrome and eosinophilic asthma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Absolute Eosinophil Count (AEC) Cutoffs for Eosinophilia

Blood eosinophilia is defined as AEC >0.5 × 10⁹/L (>500 cells/μL), hypereosinophilia as AEC ≥1.5 × 10⁹/L (≥1,500 cells/μL), and severe hypereosinophilia as AEC ≥5.0 × 10⁹/L, with specific disease thresholds varying by condition. 1, 2

Standard Eosinophilia Classification

The most recent UK guidelines (2025) establish the fundamental framework 1:

  • Mild eosinophilia: 0.5-1.5 × 10⁹/L (500-1,500 cells/μL)
  • Hypereosinophilia (HE): ≥1.5 × 10⁹/L (≥1,500 cells/μL) on two examinations at least 1 month apart
  • Severe hypereosinophilia: ≥5.0 × 10⁹/L (≥5,000 cells/μL)

Critical threshold for urgent evaluation: Any patient with eosinophilia ≥1.5 × 10⁹/L persisting >3 months without identified cause requires hematology referral after excluding infectious etiologies 1. Immediate medical assessment is mandatory for any degree of eosinophilia with evidence of end-organ damage (cardiac, pulmonary, neurologic).

Disease-Specific Cutoffs

Hypereosinophilic Syndrome (HES)

The 2020 WHO/NCCN criteria define HES as 2:

  • AEC ≥1.5 × 10⁹/L sustained for ≥6 months (or shorter if life-threatening)
  • Evidence of eosinophil-mediated end-organ damage
  • Exclusion of secondary causes

Eosinophilic Granulomatosis with Polyangiitis (EGPA)

The 2023 Nature Reviews Rheumatology guidelines specify 3:

  • Diagnostic threshold: >10% eosinophils OR >1,500 cells/μL
  • 2022 ACR-EULAR classification: AEC ≥1.0 × 10⁹/L (+5 points in scoring system)
  • Note: Glucocorticoid use can mask eosinophilia in EGPA patients

Allergic Bronchopulmonary Aspergillosis (ABPA)

The 2024 European Respiratory Journal guidelines recommend 4:

  • Blood eosinophil cutoff: ≥500 cells/μL
  • This threshold guides therapy decisions (anti-type 2 biologics, combination therapy)
  • Sputum eosinophilia may be more accurate but is underutilized

Eosinophilic Asthma

Recent 2025 data demonstrates 5:

  • Eosinophilic asthma threshold: ≥150 cells/μL
  • Exacerbation severity shows U-shaped relationship: highest admission risk at <30 or >1,000 cells/μL
  • Moderate elevation (150-300 cells/μL) associated with lowest admission risk
  • AEC ≥300 cells/μL during exacerbation predicts shorter hospital stay

Tissue Eosinophilia Standards

Eosinophilic Esophagitis (EoE)

The 2022 British Society of Gastroenterology guidelines establish 6:

  • Diagnostic threshold: >15 eosinophils per 0.3 mm² (equivalent to high-power field) in any biopsy
  • Remission: <15 eosinophils per 0.3 mm²
  • Requires 6 biopsies from ≥2 esophageal sites for 97-100% diagnostic sensitivity
  • Must exclude GERD (typically <5 eosinophils/hpf)

Chronic Rhinosinusitis with Nasal Polyps

The 2020 European Position Paper defines 7:

  • Eosinophilic CRS: 8-12 eosinophils per high-power field
  • Severe eosinophilic CRS: >55 eosinophils/HPF (highest sensitivity/specificity for recurrence prediction)
  • Stratification: 10-100 eosinophils/HPF vs >100 eosinophils/HPF in ≥2 areas

Clinical Decision Algorithm

For peripheral blood eosinophilia evaluation:

  1. AEC 0.5-1.5 × 10⁹/L (mild): Consider allergic causes, medications, parasitic infection based on travel history. Repeat in 1 month if persistent.

  2. AEC ≥1.5 × 10⁹/L (hypereosinophilia):

    • Immediately assess for end-organ damage (cardiac enzymes, echocardiogram, pulmonary function, neurologic exam)
    • If symptomatic or organ damage present: urgent hematology/cardiology consultation
    • Exclude secondary causes (parasites, drugs, malignancy)
    • If persistent >3 months without cause: hematology referral for clonal evaluation
  3. AEC ≥5.0 × 10⁹/L (severe): Urgent evaluation for HES, clonal eosinophilia, or EGPA regardless of symptoms

Common pitfall: Do not attribute hypereosinophilia (≥1.5 × 10⁹/L) to allergy alone—this threshold always warrants comprehensive workup 8. Allergic conditions typically cause mild eosinophilia only.

Important caveat: Corticosteroid therapy rapidly suppresses eosinophil counts, potentially masking underlying disease severity. Obtain baseline AEC before initiating steroids when possible 3.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.